Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Added Value of Tissue or Liquid Biopsy NGS Profiling in Advanced Solid Tumor Treatment Decisions: The Belgian PRECISION Study of the BSMO in Collaboration With the Cancer Center of Sciensano.

NCT07713550 is registered in ClinicalTrials.gov with The Belgian Society of Medical Oncology as lead sponsor.

NCT NCT07713550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07713550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Added Value of Tissue or Liquid Biopsy NGS Profiling in Advanced Solid Tumor Treatment Decisions: The Belgian PRECISION Study of the BSMO in Collaboration With the Cancer Center of Sciensano.
Lead sponsor
The Belgian Society of Medical Oncology
Phase
Observational
Overall status
Recruiting
Start date
October 22, 2025
Completion date
April 30, 2029
Enrollment
550 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor cancer, primary cns tumors